Literature DB >> 27917221

The influence of ApoE genotype on the lipid profile and lipoproteins during normal pregnancy in a Southern African population.

Donald Moshen Tanyanyiwa1, Adrian David Marais2, Pamela Byrnes2, Sheena Jones2.   

Abstract

BACKGROUND: Pregnancy is associated with increases in fasting triglycerides and total cholesterol.1 ApoE isoforms are known to influence the concentration of cholesterol, with apoE2 homozygosity lowering and apoE4 homozygosity raising the cholesterol concentration compared with E3 homozygosity.2 The lipid profiles ApoE status and prevalence of small dense LDL species were evaluated for subjects attending an antenatal clinic.
RESULTS: Samples from 690 women aged between 16 and 42 years of age were analyzed during and after pregnancy. The fasting plasma triglyceride concentration (in mmol/L) was significantly higher in pregnancy (median = 1.5, IQR 1.0-2.0 vs median = 0.6, IQR 0.5-0.8 respectively, p < 0.0001). Similarly, the total cholesterol (in mmol/L) was increased during pregnancy (median=4.1, IQR 3.6-4.7 vs median 3.5, IQR 3.1-3.5, respectively p=0.0167). The median LDL cholesterol and HDL cholesterol did not change. Higher proportions of small density LDL species were seen during pregnancy compared to after pregnancy. The distribution of the LDL species during pregnancy and 6 weeks post-partum were significantly different p<0.0001 with the smaller species being much higher during pregnancy.
CONCLUSION: ApoE4 genotype was associated with increased total cholesterol and LDL cholesterol concentrations during pregnancy. Pregnancy results in a reversible remodeling of LDL to smaller species, the significance of which is unknown but may indicate a predisposition to atherosclerosis.

Entities:  

Keywords:  African; Apolipoprotein E. Lipids; pregnancy; small dense LDL species

Mesh:

Substances:

Year:  2016        PMID: 27917221      PMCID: PMC5111999          DOI: 10.4314/ahs.v16i3.28

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  27 in total

Review 1.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

2.  Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study.

Authors:  S E Humphries; P J Talmud; E Hawe; M Bolla; I N Day; G J Miller
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

3.  Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.

Authors:  C Lahoz; E J Schaefer; L A Cupples; P W Wilson; D Levy; D Osgood; S Parpos; J Pedro-Botet; J A Daly; J M Ordovas
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

4.  Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.

Authors:  G W Cockerill; T Y Huehns; A Weerasinghe; C Stocker; P G Lerch; N E Miller; D O Haskard
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

5.  Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies.

Authors:  Luís Belo; Muriel Caslake; Dairena Gaffney; Alice Santos-Silva; Luís Pereira-Leite; Alexandre Quintanilha; Irene Rebelo
Journal:  Atherosclerosis       Date:  2002-06       Impact factor: 5.162

6.  Reference ranges of lipids and apolipoproteins in pregnancy.

Authors:  W Piechota; A Staszewski
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1992-06-16       Impact factor: 2.435

Review 7.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

Authors:  J Dallongeville; S Lussier-Cacan; J Davignon
Journal:  J Lipid Res       Date:  1992-04       Impact factor: 5.922

9.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

10.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

View more
  6 in total

1.  Infections interplay with non-communicable diseases.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

2.  Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China.

Authors:  Zhixiong Zhong; Heming Wu; Bin Li; Cunren Li; Zhidong Liu; Min Yang; Qifeng Zhang; Wei Zhong; Pingsen Zhao
Journal:  J Clin Lab Anal       Date:  2018-02-09       Impact factor: 2.352

3.  Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins.

Authors:  Ping Lv; Yaofu Zheng; Jun Huang; Junsong Ke; Hongyu Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-23       Impact factor: 2.570

4.  Frequencies and Distribution of APOE Gene Polymorphisms and Its Association With Lipid Parameters in the Senegalese Population.

Authors:  Maïmouna Touré; Niokhor N Diouf; Souleymane Thiam; Jean P Diop; Mame S Coly; Arame Mbengue; Fatou B Sar; Abdoulaye Ba; Fatou A Diallo; Abdoulaye Samb
Journal:  Cureus       Date:  2022-04-12

5.  Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China.

Authors:  Zhixiong Zhong; Heming Wu; Hesen Wu; Pingsen Zhao
Journal:  Genet Mol Biol       Date:  2018-11-29       Impact factor: 1.771

6.  Association of APOE Gene Polymorphisms with Cerebral Infarction in the Chinese Population.

Authors:  Zhixiong Zhong; Heming Wu; Min Ye; Yuxian Yang; Weixiong Luo; Yanli Wu; Hesen Wu; Miaocai Zhong; Pingsen Zhao
Journal:  Med Sci Monit       Date:  2018-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.